ReviewVaccines2023

Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon.

Mamun Al-Mahtab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.